704 related articles for article (PubMed ID: 31216433)
1. Exploring the protective effect of ShengMai-Yin and Ganmaidazao decoction combination against type 2 diabetes mellitus with nonalcoholic fatty liver disease by network pharmacology and validation in KKAy mice.
Li S; Qian Y; Xie R; Li Y; Jia Z; Zhang Z; Huang R; Tuo L; Quan Y; Yu Z; Liu J; Xiang M
J Ethnopharmacol; 2019 Oct; 242():112029. PubMed ID: 31216433
[TBL] [Abstract][Full Text] [Related]
2. Molecular mechanism of Fufang Zhenzhu Tiaozhi capsule in the treatment of type 2 diabetes mellitus with nonalcoholic fatty liver disease based on network pharmacology and validation in minipigs.
Wang H; Tan H; Zhan W; Song L; Zhang D; Chen X; Lin Z; Wang W; Yang Y; Wang L; Bei W; Guo J
J Ethnopharmacol; 2021 Jun; 274():114056. PubMed ID: 33771638
[TBL] [Abstract][Full Text] [Related]
3. Tangganjian decoction ameliorates type 2 diabetes mellitus and nonalcoholic fatty liver disease in rats by activating the IRS/PI3K/AKT signaling pathway.
Fan Y; He Z; Wang W; Li J; Hu A; Li L; Yan L; Li Z; Yin Q
Biomed Pharmacother; 2018 Oct; 106():733-737. PubMed ID: 29990865
[TBL] [Abstract][Full Text] [Related]
4. A bioinformatics and transcriptomics based investigation reveals an inhibitory role of Huanglian-Renshen-Decoction on hepatic glucose production of T2DM mice via PI3K/Akt/FoxO1 signaling pathway.
Wu F; Shao Q; Xia Q; Hu M; Zhao Y; Wang D; Fang K; Xu L; Zou X; Chen Z; Chen G; Lu F
Phytomedicine; 2021 Mar; 83():153487. PubMed ID: 33636476
[TBL] [Abstract][Full Text] [Related]
5. The effect of Liuwei Dihuang decoction on PI3K/Akt signaling pathway in liver of type 2 diabetes mellitus (T2DM) rats with insulin resistance.
Dai B; Wu Q; Zeng C; Zhang J; Cao L; Xiao Z; Yang M
J Ethnopharmacol; 2016 Nov; 192():382-389. PubMed ID: 27401286
[TBL] [Abstract][Full Text] [Related]
6. Alleviation of Fufang Fanshiliu decoction on type II diabetes mellitus by reducing insulin resistance: A comprehensive network prediction and experimental validation.
Dai W; Chen C; Dong G; Li G; Peng W; Liu X; Yang J; Li L; Xu R; Hu X
J Ethnopharmacol; 2022 Aug; 294():115338. PubMed ID: 35568115
[TBL] [Abstract][Full Text] [Related]
7. Liver Lipidomics Analysis Revealed the Protective mechanism of Zuogui Jiangtang Qinggan Formula in type 2 diabetes mellitus with non-alcoholic fatty liver disease.
Zhou M; Liu X; Wu Y; Xiang Q; Yu R
J Ethnopharmacol; 2024 Jul; 329():118160. PubMed ID: 38588985
[TBL] [Abstract][Full Text] [Related]
8. Exploring the mechanism of PingTang No.5 capsule on nonalcoholic fatty liver disease through network pharmacology and experimental validation.
Hung TC; Zhao N; Huang C; Liu S; Liu T; Huang W; Xu X; Ji ZL; Yang S
Biomed Pharmacother; 2021 Jun; 138():111408. PubMed ID: 33684693
[TBL] [Abstract][Full Text] [Related]
9. The Effect of Sanggua Drink Extract on Insulin Resistance through the PI3K/AKT Signaling Pathway.
Cai Y; Wang Y; Zhi F; Xing QC; Chen YZ
Evid Based Complement Alternat Med; 2018; 2018():9407945. PubMed ID: 29670663
[TBL] [Abstract][Full Text] [Related]
10. Scutellariae Radix and Coptidis Rhizoma Improve Glucose and Lipid Metabolism in T2DM Rats via Regulation of the Metabolic Profiling and MAPK/PI3K/Akt Signaling Pathway.
Cui X; Qian DW; Jiang S; Shang EX; Zhu ZH; Duan JA
Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30453687
[No Abstract] [Full Text] [Related]
11. MDG-1, a polysaccharide from Ophiopogon japonicus exerts hypoglycemic effects through the PI3K/Akt pathway in a diabetic KKAy mouse model.
Wang LY; Wang Y; Xu DS; Ruan KF; Feng Y; Wang S
J Ethnopharmacol; 2012 Aug; 143(1):347-54. PubMed ID: 22776833
[TBL] [Abstract][Full Text] [Related]
12. Study on the mechanism of Gegen Qinlian Decoction for treating type II diabetes mellitus by integrating network pharmacology and pharmacological evaluation.
Xu X; Niu L; Liu Y; Pang M; Lu W; Xia C; Zhu Y; Yang B; Wang Q
J Ethnopharmacol; 2020 Nov; 262():113129. PubMed ID: 32730886
[TBL] [Abstract][Full Text] [Related]
13. A novel formula Sang-Tong-Jian improves glycometabolism and ameliorates insulin resistance by activating PI3K/AKT pathway in type 2 diabetic KKAy mice.
Kuai M; Li Y; Sun X; Ma Z; Lin C; Jing Y; Lu Y; Chen Q; Wu X; Kong X; Bian H
Biomed Pharmacother; 2016 Dec; 84():1585-1594. PubMed ID: 27829545
[TBL] [Abstract][Full Text] [Related]
14. Xiao Ke Qing improves glycometabolism and ameliorates insulin resistance by regulating the PI3K/Akt pathway in KKAy mice.
Li X; Li X; Wang G; Xu Y; Wang Y; Hao R; Ma X
Front Med; 2018 Dec; 12(6):688-696. PubMed ID: 30421394
[TBL] [Abstract][Full Text] [Related]
15. Based on network pharmacology to explore the effect and mechanism of Yipibushen decoction in improving obese type 2 diabetes mellitus with oligoasthenotspermia.
Li G; Wang Q; Chen X; Yu P; Peng Q; Chen H; Ren S; Wang C; Su Y; Liang X; Sun M; Du X; He R
J Ethnopharmacol; 2023 Dec; 317():116738. PubMed ID: 37369336
[TBL] [Abstract][Full Text] [Related]
16. Identify Molecular Mechanisms of Jiangzhi Decoction on Nonalcoholic Fatty Liver Disease by Network Pharmacology Analysis and Experimental Validation.
Wang L; Zhi Y; Ye Y; Zhang M; Ma X; Tie H; Ma X; Zheng N; Xia W; Song Y
Biomed Res Int; 2020; 2020():8829346. PubMed ID: 33415161
[TBL] [Abstract][Full Text] [Related]
17. Agriophyllum oligosaccharides ameliorate hepatic injury in type 2 diabetic db/db mice targeting INS-R/IRS-2/PI3K/AKT/PPAR-γ/Glut4 signal pathway.
Bao S; Wu YL; Wang X; Han S; Cho S; Ao W; Nan JX
J Ethnopharmacol; 2020 Jul; 257():112863. PubMed ID: 32302715
[TBL] [Abstract][Full Text] [Related]
18. Study on the action mechanism of the Polygonum perfoliatum L. on non-alcoholic fatty liver disease, based on network pharmacology and experimental validation.
Liu G; Yang L; Tang Y; Lin J; Wang F; Shen J; Chang B; Kong X
J Ethnopharmacol; 2024 Jan; 319(Pt 3):117330. PubMed ID: 37863399
[TBL] [Abstract][Full Text] [Related]
19. Sanhuang xiexin decoction synergizes insulin/PI3K-Akt/FoxO signaling pathway to inhibit hepatic glucose production and alleviate T2DM.
Chen D; Chen X; He C; Xiao C; Chen Z; Chen Q; Chen J; Bo H
J Ethnopharmacol; 2023 Apr; 306():116162. PubMed ID: 36646159
[TBL] [Abstract][Full Text] [Related]
20. Anti-Diabetic Effects of Jiang Tang Xiao Ke Granule via PI3K/Akt Signalling Pathway in Type 2 Diabetes KKAy Mice.
Yu N; Fang X; Zhao D; Mu Q; Zuo J; Ma Y; Zhang Y; Mo F; Zhang D; Jiang G; Wu R; Gao S
PLoS One; 2017; 12(1):e0168980. PubMed ID: 28045971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
